A volunteer died during an Alzeheimer’s drug trial run by Tokyo-based drugmaker Eisai and Cambridge, Mass.-based Biogen. Eisai said the cause of death is unclear.
Read the full post on Becker's Hospital Review - Healthcare News
Study participant died during Eisai’s Alzheimer’s drug trial
